Skip to content

Development and application of clinical trial hesitation scale for tumor patients

Development and application of clinical trial hesitation scale for tumor patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093749
Enrollment
Unknown
Registered
2024-12-11
Start date
2024-04-23
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Trail group:NA

Sponsors

West China Tianfu Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The diagnosis of lung cancer was confirmed by cytology and pathology, and the patient knew his own disease and diagnosis; 2.Be invited to participate in a clinical trial within 6 months or are currently in the clinical trial recruitment stage; 3.Volunteer to participate in the study and sign the informed consent document; 4.Age > 18 years old;

Exclusion criteria

Exclusion criteria: 1.Have a mental illness: if diagnosed with a serious mental illness, or are receiving psychological treatment; 2.Combined with other serious diseases: such as heart disease, kidney failure, etc. 3.Patients with no obvious hesitation in the decision-making process.

Design outcomes

Primary

MeasureTime frame
reliability and validity;hesitation;

Countries

China

Contacts

Public ContactHuang Yueting

West China Tianfu Hospital of Sichuan University

397328721@qq.com+86 18227599134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026